---
title: "CHINARES PHARMA has completed the issuance of 1.5 billion RMB corporate bonds with an interest rate of 1.65%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283019587.md"
description: "CHINARES PHARMA announced that its wholly-owned subsidiary, CHINARES PHARMA Holdings, has completed the issuance of 2026 corporate bonds (Phase I) with a principal amount of 1.5 billion RMB, a term of three years, and a coupon rate of 1.65%. The funds raised in this phase will be used for productive expenditures"
datetime: "2026-04-16T14:28:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283019587.md)
  - [en](https://longbridge.com/en/news/283019587.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283019587.md)
---

# CHINARES PHARMA has completed the issuance of 1.5 billion RMB corporate bonds with an interest rate of 1.65%

CHINARES PHARMA (03320.HK) announced that its wholly-owned subsidiary, CHINARES PHARMA Holdings, has completed the issuance of 2026 corporate bonds (Phase I) with a principal amount of 1.5 billion RMB, a term of three years, and a coupon rate of 1.65%. The funds raised in this phase will be used for production-related expenditures

### Related Stocks

- [03320.HK](https://longbridge.com/en/quote/03320.HK.md)

## Related News & Research

- [China Resources Pharmaceutical Completes RMB1.4 Billion Second Tranche of 2026 Bonds in China](https://longbridge.com/en/news/284352645.md)
- [Bank of India hikes interest rates on select medium and long-term deposits](https://longbridge.com/en/news/286721327.md)
- [Mortgage rates continue to rise as bond yields climb](https://longbridge.com/en/news/287115793.md)
- [The Bond Market Just Flashed A Major Warning](https://longbridge.com/en/news/286549826.md)
- [China's Benchmark Lending Rates Kept Unchanged](https://longbridge.com/en/news/286989758.md)